Evidence map›Paper›PMID 15171792›Full record

ArticleBMC medical genetics2004

Elevated white cell count in acute coronary syndromes: relationship to variants in inflammatory and thrombotic genes.

Connie E Byrne, Anthony Fitzgerald, Christopher P Cannon, Desmond J Fitzgerald, Denis C Shields

Open access · goldAbstract readComparative Study
In one paragraph

Article in BMC medical genetics, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Blood Leukocyte Count on Admission Predicts Cardiovascular Events in Patients with Acute Non-ST Elevation Myocardial Infarction.The International journal of angiology : official publication of the International College of Angiology, Inc · 2015
    Article
  6. Article
  7. Cardiac gene expression and systemic cytokine profile are complementary in a murine model of post-ischemic heart failure.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Connie E ByrneDepartment of Clinical Pharmacology, Royal College of Surgeons in Ireland, 123 St Stephen's Green, Dublin 2, Ireland. cbyrne@rcsi.ie
Anthony Fitzgerald
Christopher P Cannon
Desmond J Fitzgerald
Denis C Shields
Royal College of Surgeons in Ireland · IEHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundElevated white blood cell counts (WBC) in acute coronary syndromes (ACS) increase the risk of recurrent events, but it is not known if this is exacerbated by pro-inflammatory factors. We sought to identify whether pro-inflammatory genetic variants contributed to alterations in WBC and C-reactive protein (CRP) in an ACS population.

methodsWBC and genotype of interleukin 6 (IL-6 G-174C) and of interleukin-1 receptor antagonist (IL1RN intronic repeat polymorphism) were investigated in 732 Caucasian patients with ACS in the OPUS-TIMI-16 trial. Samples for measurement of WBC and inflammatory factors were taken at baseline, i.e. Within 72 hours of an acute myocardial infarction or an unstable angina event.

resultsAn increased white blood cell count (WBC) was associated with an increased C-reactive protein (r = 0.23, p < 0.001) and there was also a positive correlation between levels of beta-fibrinogen and C-reactive protein (r = 0.42, p < 0.0001). IL1RN and IL6 genotypes had no significant impact upon WBC. The difference in median WBC between the two homozygote IL6 genotypes was 0.21/mm3 (95% CI = -0.41, 0.77), and -0.03/mm3 (95% CI = -0.55, 0.86) for IL1RN. Moreover, the composite endpoint was not significantly affected by an interaction between WBC and the IL1 (p = 0.61) or IL6 (p = 0.48) genotype.

conclusionsCytokine pro-inflammatory genetic variants do not influence the increased inflammatory profile of ACS patients.

Indexed as

Leukocyte CountAcute DiseaseAngina, UnstableBiomarkersClinical Trials as TopicCoronary ThrombosisC-Reactive ProteinFibrinogenGenetic VariationGenotypeHumansInflammationInterleukin 1 Receptor Antagonist ProteinInterleukin-6Myocardial InfarctionPolymorphism, GeneticBiomarkersC-Reactive ProteinFibrinogenIL1RN protein, humanInterleukin 1 Receptor Antagonist ProteinInterleukin-6Sialoglycoproteins

Identifiers

PMID15171792
PMCPMC425582
OpenAlexW1844887822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.